factory supply 99% Hydroxyurea CAS NO.127-07-1
- FOB Price: USD: 25.00-500.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
Medicine Grade(1-99)KilogramMedicine Grade(100-1000)Kilogram
- Product Details
Keywords
- Hydroxyurea
- High purity 99%
- factory supply
Quick Details
- ProName: factory supply 99% Hydroxyurea
- CasNo: 127-07-1
- Molecular Formula: CH4N2O2
- Appearance: White powder
- Application: An anti-neoplastic - inhibits ribonucl...
- DeliveryTime: in 7 days afte your payment ( in stock...
- PackAge: 1kg/bag ;5kg/drum:25KG/drum
- Port: any port in China
- ProductionCapacity: 20 Metric Ton/Month
- Purity: 99% up
- Storage: in low tempreture
- Transportation: in low tempreture
- LimitNum: 1 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Why choose us
1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin
Details
Product Information
Chemical Name |
hydroxyurea |
---|---|
Synonyms |
Hydroxycarbamide;Droxia;amino-hydroxamic acid;Hydrea;N-HYDROXYUREA |
CAS No. |
127-07-1 |
Molecular Formula |
CH4N2O2 |
Molecular Weight |
76.05470 |
PSA |
75.35000 |
LogP |
0.13510 |
Function
Antimetabolic anticancer drugs, mainly acting on the G1 and S phase of proliferating cells, have a retarding effect on the G1/S interface, and are cell specific drugs.Antitumor.Chemicalbook nucleoside reductase is inactivated by the formation of free nitric oxide that binds to tyrosine at the active site of the enzyme.This prevents the synthesis of deoxynucleotides from being used medically for the treatment of chronic myeloid leukemia, metastatic ovarian cancer, primary squamous cell carcinoma of the head and neck, and refractory psoriasis.This product is an anti-tumor drug.